血塞通在老年人急性脑梗死治疗中的临床价值分析

Clinical Research on Xuesaitong for the Treatment of Elderly Patients with Acute Cerebral Infarction

目的:探讨血塞通在老年人急性脑梗死治疗中的临床应用价值。方法:将本院2011年1月～2011年12月在本院诊治的82例急性脑梗死患者随机分成2组:①实验组41例;②对照组41例。对照组单纯给予阿托伐他汀治疗;实验组给予阿托伐他汀+血塞通治疗。观察比较两组的临床疗效、血凝系统和血液流变学的变化情况。结果:实验组的总有效率为82.93%,对照组的总有效率为56.09%,实验组的临床疗效明显优于对照组(P<0.05);实验组患者治疗后的Fbg、TT、PT、INR、APTT指标水平均显著性优于对照组(P<0.05);实验组患者治疗后的高切ηb、低切ηb、FIB、ηp、HCT指标水平均显著性优于对照组(P<0.05)。结论:临床应用血塞通治疗急性脑梗死的效果显著。

Objective：To investigate the clinical value about Xuesaitong for the treatment of elderly patients with acute cerebral infarction.Methods：The 82 cases of elderly acute cerebral infarction patients admitted to hospital from January 2010 to December 2011 were randomly divided into two groups,control group（n=41） and treatment group（n=41）.The control group was treated with atorvastatin only,but the treatment group was treated with atorvastatin and Xuesaitong.The clinical effects,the changes of coagulation system and hemorheological in 2 groups was observed and compared.Results：The total effective rate was 82.93% in the treatment group,but the control group was 56.09%,so the clinical effects in the treatment group was significantly better than the control group（P0.05）;the index value of Fbg,TT,PT,INR,APTT in the treatment group after treated were significantly better than the control group（P0.05）;the index value of ηb,FIB,ηp,HCT in the treatment group after treated were significantly better than the control group（P0.05）.Conclusion：There is a significant clinical effect of Xuesaitong for the treatment of elderly patients with acute cerebral infarction.